Search results for "Coronavirus"
Call for submissions: ACP Hospitalist wants your pandemic stories
Submit your short article about a strategy, patient or colleague interaction, or other aspect of hospital practice during the pandemic by Aug. 31, and it may be published in the November ACP Hospitalist.
https://acphospitalist.acponline.org/weekly/archives/2020/08/05/2.htm
5 Aug 2020
New research on steroids, tocilizumab, interferon beta-1a in COVID-19 inpatients
A 12-mg dose of dexamethasone didn't work any better than 6 mg in a trial of patients with severe hypoxemia, tocilizumab seemed to outperform steroids only in patients with the most inflammation, and interferon beta-1a did not help hospitalized patients on remdesivir.
https://acphospitalist.acponline.org/weekly/archives/2021/10/27/1.htm
27 Oct 2021
Recent guidance offered on preparing to treat COVID-19
ACP continues to press the government to do more to address the novel coronavirus disease (COVID-19) and expand coverage of and access to testing and treatment.
https://acphospitalist.acponline.org/weekly/archives/2020/03/18/1.htm
18 Mar 2020
Anaphylaxis appears rare with COVID-19 vaccine, alternative dosing strategies considered
The CDC's monitoring system found low rates of anaphylaxis after a first dose of the Pfizer-BioNTech COVID-19 vaccine, peer-reviewed data were published on the Moderna vaccine, and single-dose vaccine strategies were considered.
https://acphospitalist.acponline.org/weekly/archives/2021/01/13/2.htm
13 Jan 2021
Substance use problems in the U.S. exacerbated by pandemic, studies indicate
The percentage of urine tests that were positive for illicit drugs increased, an ED saw more nonfatal opioid overdoses, and experts offered hospitalist-specific advice on handling substance use disorders.
https://acphospitalist.acponline.org/weekly/archives/2020/09/30/2.htm
30 Sep 2020
Tocilizumab for COVID-19 shows mixed results in large number of new studies
A randomized trial did not find benefit from tocilizumab, and the results were mixed from a smaller trial and retrospective analyses. An editorialist said that evidence does not yet support routine use of the drug for COVID-19 and suggested “wait[ing] out the torrent” of research.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/2.htm
28 Oct 2020
Avoiding SNFs and antibiotics, expecting long-term effects and boosters in COVID-19
One study showed how a new committee reduced discharges to skilled nursing facilities (SNFs) while another indicated that empiric antibiotics aren't necessary for ventilated COVID-19 patients. Officials announced plans for vaccine boosters, and convalescent plasma failed an outpatient trial.
https://acphospitalist.acponline.org/weekly/archives/2021/08/25/1.htm
25 Aug 2021
COVID-19 and obesity, AKI, DKA, antibiotics, symptom checkers, hospital prep
Acute kidney injury (AKI) and diabetic ketoacidosis (DKA) were worse with COVID-19, antibiotics were overused, and an online symptom checker didn't triage safely, but most hospitals had enough ICU beds and preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://acphospitalist.acponline.org/weekly/archives/2021/03/17/1.htm
17 Mar 2021
May issue online and in the mail
This issue focuses mainly on tools to combat COVID-19, including ventilation management, telemedicine, and palliative care. Other articles address Takotsubo cardiomyopathy and vitamin C for sepsis.
https://acphospitalist.acponline.org/weekly/archives/2020/05/13/6.htm
13 May 2020
Latest COVID-19 research focuses on another drug, racial disparities, early infections
A Brazilian trial found benefit from tofacitinib in hospitalized patients, while a study of Medicare patients showed racial disparities might stem from differences between hospitals.
https://acphospitalist.acponline.org/weekly/archives/2021/06/23/1.htm
23 Jun 2021